Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06979362) titled 'A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy' on May 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Heart Failure
Intervention:
Drug: CDR132L
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: July 1, 2025
Tar...